中国医药：子公司盐酸林可霉素注射液通过仿制药一致性评价

Core Viewpoint - The company Tianfang Pharmaceutical, a wholly-owned subsidiary of China Pharmaceutical, has received approval from the National Medical Products Administration for its product, Lincomycin Hydrochloride Injection, which has passed the consistency evaluation of quality and efficacy for generic drugs [1] Group 1 - The approved drug, Lincomycin Hydrochloride Injection, is primarily used to treat severe infections caused by sensitive strains of bacteria such as Streptococcus, Pneumococcus, and Staphylococcus [1]